KR101133723B1 - 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도 - Google Patents

소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도 Download PDF

Info

Publication number
KR101133723B1
KR101133723B1 KR1020100097774A KR20100097774A KR101133723B1 KR 101133723 B1 KR101133723 B1 KR 101133723B1 KR 1020100097774 A KR1020100097774 A KR 1020100097774A KR 20100097774 A KR20100097774 A KR 20100097774A KR 101133723 B1 KR101133723 B1 KR 101133723B1
Authority
KR
South Korea
Prior art keywords
composition
vaginitis
salt
present
vaginal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020100097774A
Other languages
English (en)
Korean (ko)
Other versions
KR20110043448A (ko
Inventor
최원석
권동열
Original Assignee
최원석
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44048707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101133723(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 최원석 filed Critical 최원석
Priority to NZ599265A priority Critical patent/NZ599265A/en
Priority to RU2012113101/15A priority patent/RU2536264C2/ru
Priority to JP2012534113A priority patent/JP6044831B2/ja
Priority to BR112012008470A priority patent/BR112012008470A2/pt
Priority to MX2012004509A priority patent/MX2012004509A/es
Priority to HK12108229.2A priority patent/HK1167348B/xx
Priority to CN2010800466317A priority patent/CN102573858B/zh
Priority to PCT/KR2010/007068 priority patent/WO2011049327A2/en
Priority to MYPI2012001746A priority patent/MY182983A/en
Priority to EP17159197.7A priority patent/EP3192516A1/en
Priority to AU2010308741A priority patent/AU2010308741B2/en
Priority to CA2778371A priority patent/CA2778371C/en
Priority to EP10825152.1A priority patent/EP2490700A4/en
Priority to PH1/2012/500773A priority patent/PH12012500773A1/en
Priority to US13/501,910 priority patent/US20120201904A1/en
Publication of KR20110043448A publication Critical patent/KR20110043448A/ko
Application granted granted Critical
Publication of KR101133723B1 publication Critical patent/KR101133723B1/ko
Priority to US14/025,698 priority patent/US20140037758A1/en
Priority to US14/025,654 priority patent/US9408868B2/en
Priority to US14/450,637 priority patent/US9433641B2/en
Priority to US14/451,432 priority patent/US9446069B2/en
Assigned to 주식회사 하우동천 reassignment 주식회사 하우동천 권리의 일부이전등록 Assignors: 최원석
Priority to JP2016172680A priority patent/JP6429131B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020100097774A 2009-10-19 2010-10-07 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도 Active KR101133723B1 (ko)

Priority Applications (20)

Application Number Priority Date Filing Date Title
PH1/2012/500773A PH12012500773A1 (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
EP10825152.1A EP2490700A4 (en) 2009-10-19 2010-10-15 EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF
JP2012534113A JP6044831B2 (ja) 2009-10-19 2010-10-15 膣症を予防および治療するために塩および糖を有効成分として含む皮膚外用組成物およびその使用
BR112012008470A BR112012008470A2 (pt) 2009-10-19 2010-10-15 composição externa para pele para a prevenção e tratamento da vaginose, uso e método para preparar a mesma
MX2012004509A MX2012004509A (es) 2009-10-19 2010-10-15 Composicion externa para la piel que comprende una sal y azucar como ingredientes activos para prevenir y tratar la vaginosis y uso de la misma.
HK12108229.2A HK1167348B (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
CN2010800466317A CN102573858B (zh) 2009-10-19 2010-10-15 用于预防和治疗阴道病的含有盐和糖作为活性成分的皮肤外用组合物及其用途
PCT/KR2010/007068 WO2011049327A2 (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MYPI2012001746A MY182983A (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
EP17159197.7A EP3192516A1 (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
AU2010308741A AU2010308741B2 (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
RU2012113101/15A RU2536264C2 (ru) 2009-10-19 2010-10-15 Композиция для наружного применения на коже, содержащая соль и сахар в качестве активных ингредиентов, для предотвращения и лечения вагиноза, и ее применение
NZ599265A NZ599265A (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
CA2778371A CA2778371C (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
US13/501,910 US20120201904A1 (en) 2009-10-19 2010-10-15 Skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
US14/025,698 US20140037758A1 (en) 2009-10-19 2013-09-12 Skin external composition comprising a melted salt and suagr as active ingredients for preventing and treating vaginosis and the use thereof
US14/025,654 US9408868B2 (en) 2009-10-19 2013-09-12 Skin external composition comprising a combination of sodium chloride and glucose as active ingredients for treating vaginosis and the use thereof
US14/450,637 US9433641B2 (en) 2009-10-19 2014-08-04 Skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
US14/451,432 US9446069B2 (en) 2009-10-19 2014-08-05 Skin external composition comprising a sea salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
JP2016172680A JP6429131B2 (ja) 2009-10-19 2016-09-05 膣症を予防および治療するために塩および糖を有効成分として含む皮膚外用組成物およびその使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090099333 2009-10-19
KR20090099333 2009-10-19

Publications (2)

Publication Number Publication Date
KR20110043448A KR20110043448A (ko) 2011-04-27
KR101133723B1 true KR101133723B1 (ko) 2012-04-09

Family

ID=44048707

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100097774A Active KR101133723B1 (ko) 2009-10-19 2010-10-07 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도

Country Status (14)

Country Link
US (2) US20120201904A1 (https=)
EP (2) EP3192516A1 (https=)
JP (2) JP6044831B2 (https=)
KR (1) KR101133723B1 (https=)
CN (1) CN102573858B (https=)
AU (1) AU2010308741B2 (https=)
BR (1) BR112012008470A2 (https=)
CA (1) CA2778371C (https=)
MX (1) MX2012004509A (https=)
MY (1) MY182983A (https=)
NZ (1) NZ599265A (https=)
PH (1) PH12012500773A1 (https=)
RU (1) RU2536264C2 (https=)
WO (1) WO2011049327A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101771479B1 (ko) 2016-12-23 2017-09-05 유한회사 아이에스티케이3 천연식물추출물 및 당을 유효성분으로 함유하는 질염예방 및 치료용 조성물
KR102213286B1 (ko) 2020-07-31 2021-02-05 정소영 질염의 치료 및 자궁경부이형성증의 예방용 한약 조성물
KR20210088790A (ko) 2020-01-06 2021-07-15 주식회사 벤스랩 염화칼륨을 포함하는 여성세정제 조성물

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9433641B2 (en) * 2009-10-19 2016-09-06 Won Seog Choi Skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
JP5547123B2 (ja) * 2011-03-30 2014-07-09 株式会社 資生堂 油中水型乳化化粧料
KR101470282B1 (ko) * 2013-10-01 2014-12-05 최원석 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도
KR102587444B1 (ko) 2015-09-29 2023-10-11 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승 조성물
KR101784847B1 (ko) * 2016-05-10 2017-10-13 주식회사 하우동천 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도
MX389431B (es) 2017-02-28 2025-03-20 Kimberly Clark Co Composicion sinergica para el mantenimiento del equilibrio saludable de la microflora.
KR102091440B1 (ko) * 2018-07-26 2020-03-20 이기용 질 세정제를 이용한 질 세정용 위생용품
RU2726123C1 (ru) * 2019-12-20 2020-07-09 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Способ лечения трихомониаза у женщин
JPWO2024262189A1 (https=) * 2023-06-20 2024-12-26

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010029068A (ko) * 1999-09-29 2001-04-06 강권중 죽염과 운모를 유효성분으로 함유하는 질정제
US20060105963A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Therapeutic agents for inhibiting and/or treating vaginal infection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823163A (en) * 1956-10-11 1958-02-11 Richard K Thoms Antivaginitis process and cation exchange resin composition
IT1172185B (it) * 1981-12-21 1987-06-18 Serono Ist Farm Composizione particolarmente per la vande vaginali
DE3232136A1 (de) * 1982-08-28 1984-03-01 Ruth Cegla GmbH, 7542 Schömberg Gemisch enthaltend meersalz und/oder salinensalz
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
US5098709A (en) * 1987-07-21 1992-03-24 Kang Kwon J Method of administrating a fused salt from natural substances, namely ginkgo, persimmon, pine, and bamboo in the treatment of inflammations
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
AU675304B2 (en) * 1993-06-04 1997-01-30 Senju Pharmaceutical Co., Ltd. Ophthalmic topical agent
US5916176A (en) * 1994-08-25 1999-06-29 Caillouette; James C. Estrogen or estradiol need determination by vaginal or urethral acidity determination
WO1997043989A1 (en) * 1996-05-22 1997-11-27 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
DE69831878D1 (de) * 1997-11-24 2006-02-23 Zhongming Zeng Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
RU2234325C1 (ru) * 2003-12-10 2004-08-20 ЗАО "Аэромед" Способ лечения заболеваний влагалища и устройство для его осуществления (варианты)
CN100389763C (zh) * 2004-02-10 2008-05-28 周世兰 改善妇女阴道酸、湿性的乳酸、甘油制剂
SE528337C2 (sv) * 2004-06-23 2006-10-24 Nestor Medical Ab Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet
US20080286384A1 (en) * 2004-09-15 2008-11-20 Renee Reichert Topical Wound Care Product Containing Hyssop
RU2409368C2 (ru) * 2005-04-27 2011-01-20 Шэньчжэнь Флора Байотекнолоджи Лимитед Композиция и способ регуляции и поддержания бактериальной микрофлоры и кислотности влагалища
US20090232939A1 (en) * 2006-01-24 2009-09-17 Fjell & Fjord Mat As Composition comprising sugar and salt for treating meat
JP5199551B2 (ja) * 2006-07-06 2013-05-15 サンスター株式会社 カンジダ菌感染に基づく疾患の予防又は改善剤
CN101530403A (zh) * 2008-03-14 2009-09-16 郭进军 用于治疗或预防妇女阴道炎、宫颈糜烂的木糖醇组合物
CN101797269B (zh) * 2010-03-23 2012-01-04 杨霞 一种调节女性阴道微生态的生理平衡液

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010029068A (ko) * 1999-09-29 2001-04-06 강권중 죽염과 운모를 유효성분으로 함유하는 질정제
US20060105963A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Therapeutic agents for inhibiting and/or treating vaginal infection

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101771479B1 (ko) 2016-12-23 2017-09-05 유한회사 아이에스티케이3 천연식물추출물 및 당을 유효성분으로 함유하는 질염예방 및 치료용 조성물
KR20210088790A (ko) 2020-01-06 2021-07-15 주식회사 벤스랩 염화칼륨을 포함하는 여성세정제 조성물
KR102213286B1 (ko) 2020-07-31 2021-02-05 정소영 질염의 치료 및 자궁경부이형성증의 예방용 한약 조성물

Also Published As

Publication number Publication date
NZ599265A (en) 2014-03-28
EP3192516A1 (en) 2017-07-19
CN102573858A (zh) 2012-07-11
WO2011049327A3 (en) 2011-10-20
HK1167348A1 (en) 2012-11-30
CA2778371A1 (en) 2011-04-28
MY182983A (en) 2021-02-05
BR112012008470A2 (pt) 2016-04-05
JP6044831B2 (ja) 2016-12-14
JP2013508269A (ja) 2013-03-07
CN102573858B (zh) 2013-09-18
JP6429131B2 (ja) 2018-11-28
MX2012004509A (es) 2012-06-04
WO2011049327A2 (en) 2011-04-28
PH12012500773A1 (en) 2016-10-26
AU2010308741B2 (en) 2015-02-19
US20120201904A1 (en) 2012-08-09
EP2490700A4 (en) 2013-08-07
AU2010308741A1 (en) 2012-05-03
EP2490700A2 (en) 2012-08-29
US20140037758A1 (en) 2014-02-06
CA2778371C (en) 2017-09-05
RU2012113101A (ru) 2013-11-27
KR20110043448A (ko) 2011-04-27
JP2017025078A (ja) 2017-02-02
RU2536264C2 (ru) 2014-12-20

Similar Documents

Publication Publication Date Title
KR101133723B1 (ko) 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
KR101287126B1 (ko) 식물성유산균발효액을 함유하는 질염 및 요로감염 예방 및 치료용 약학 조성물
US20170071990A1 (en) Compositions containing boric acid and a mixture of lactobacillus
EP3548045A1 (en) Urogenital medical device formulation based on suitable biochemical compositions for the stabilization of the acidity and the redox state of the vaginal fluid
CN109985069B (zh) 益生菌组合物及其用途
CN111449973A (zh) 一种修复女性阴道微生态平衡的泡沫剂及其制备方法
EP2643003B1 (en) Vaginal composition based on alkyl polyglucosides
EP1784176B1 (en) Composition comprising lactic acid and lactoferrin
CN105232526A (zh) 含儿茶素的药物在制备抑菌药物中的用途
KR101771479B1 (ko) 천연식물추출물 및 당을 유효성분으로 함유하는 질염예방 및 치료용 조성물
CN101543514A (zh) 预防或治疗阴道炎的复合乳酸菌洁阴护理液及工艺
KR102014810B1 (ko) 질염 예방 및 치료용 조성물
TWI412371B (zh) 抑制陰道炎病原菌之乳酸桿菌及其用途
CN118726136A (zh) 一株可调节生殖道微生态和修复生殖道黏膜屏障损伤的鼠李糖乳酪杆菌bb520及其应用
US9408868B2 (en) Skin external composition comprising a combination of sodium chloride and glucose as active ingredients for treating vaginosis and the use thereof
KR102285430B1 (ko) 염화칼륨을 포함하는 여성세정제 조성물
EP2886117B1 (en) Topical compositions for the treatment of Gardnerella vaginalis infections
KR20220161713A (ko) 질염 예방 또는 치료용 조성물
US9433641B2 (en) Skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
KR102588878B1 (ko) 질염 및 질건조증 개선 조성물, 및 이를 포함하는 질염 및 질건조 개선제
KR100892304B1 (ko) 나한백 정유를 포함하는 칸디다증의 치료 또는 예방용조성물
HK1167348B (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A302 Request for accelerated examination
PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

A302 Request for accelerated examination
PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

S20-X000 Security interest recorded

St.27 status event code: A-4-4-S10-S20-lic-X000

FPAY Annual fee payment

Payment date: 20150224

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

S22-X000 Recordation of security interest cancelled

St.27 status event code: A-4-4-S10-S22-lic-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20160316

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

P14-X000 Amendment of ip right document requested

St.27 status event code: A-5-5-P10-P14-nap-X000

FPAY Annual fee payment

Payment date: 20170321

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

St.27 status event code: A-5-5-V10-V11-apl-PJ0204

J301 Trial decision

Free format text: TRIAL NUMBER: 2017100002999; TRIAL DECISION FOR INVALIDATION REQUESTED 20170920

Effective date: 20171228

PJ1301 Trial decision

St.27 status event code: A-5-5-V10-V15-crt-PJ1301

Decision date: 20171228

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1133723

Appeal request date: 20170920

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2017100002999

FPAY Annual fee payment

Payment date: 20180119

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

J2X1 Appeal (before the patent court)

Free format text: TRIAL NUMBER: 2018200001509; INVALIDATION

PJ2001 Appeal

St.27 status event code: A-5-5-V10-V12-crt-PJ2001

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

FPAY Annual fee payment

Payment date: 20190225

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

J302 Written judgement (patent court)

Free format text: TRIAL NUMBER: 2018200001509; JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20180125

Effective date: 20190222

PJ1302 Judgment (patent court)

St.27 status event code: A-5-5-V10-V15-crt-PJ1302

Decision date: 20190222

Decision identifier: 2018200001509

Decision authority category: National patent court

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 20172999 (1133723)

Appeal request date: 20180125

Appellate body name: Patent Court

FPAY Annual fee payment

Payment date: 20200331

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20210125

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20220316

Year of fee payment: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 14

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 15

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 15